Salobel


Indications and Reactions:

Role Indications Reactions
Secondary
Hypertension 38.5%
Hyperuricaemia 18.5%
Colon Cancer Metastatic 4.6%
Gastritis 4.6%
Hyperlipidaemia 4.6%
Renal Transplant 4.6%
Cardiac Failure 3.1%
Pruritus 3.1%
Central Pain Syndrome 2.3%
Depression 2.3%
Pneumonia Aspiration 2.3%
Angina Pectoris 1.5%
Cerebral Infarction 1.5%
Constipation 1.5%
Large Intestine Carcinoma 1.5%
Product Used For Unknown Indication 1.5%
Rhinitis 1.5%
Blood Uric Acid Increased 0.8%
Hypertriglyceridaemia 0.8%
Insomnia 0.8%
Stevens-johnson Syndrome 28.6%
Blood Potassium Increased 11.4%
Drug Eruption 11.4%
Interstitial Lung Disease 5.7%
Red Blood Cell Count Decreased 5.7%
Gamma-glutamyltransferase Increased 2.9%
Glomerulonephritis Rapidly Progressive 2.9%
Intentional Drug Misuse 2.9%
Loss Of Consciousness 2.9%
Pneumonia 2.9%
Pulmonary Haemorrhage 2.9%
Rhinitis 2.9%
Scab 2.9%
Stasis Dermatitis 2.9%
Vasculitis 2.9%
Vomiting 2.9%
White Blood Cell Count Decreased 2.9%
White Blood Cell Count Increased 2.9%
Concomitant
Hypertension 20.1%
Product Used For Unknown Indication 12.8%
Hyperuricaemia 9.3%
Prophylaxis 8.4%
Chronic Hepatitis C 6.5%
Hyperlipidaemia 4.8%
Drug Use For Unknown Indication 4.4%
Diabetes Mellitus 4.0%
Pulmonary Arterial Hypertension 3.7%
Hepatitis C 3.2%
Asthma 3.1%
Gastritis 3.0%
Chronic Myeloid Leukaemia 2.5%
Insomnia 2.3%
Cardiac Failure 2.2%
Constipation 2.0%
Angina Pectoris 2.0%
Cardiac Failure Chronic 2.0%
Pneumonia 1.9%
Adult T-cell Lymphoma/leukaemia 1.8%
White Blood Cell Count Decreased 13.8%
Pyrexia 8.2%
Platelet Count Decreased 7.5%
Renal Impairment 7.5%
Anaemia 6.9%
Pneumonia 5.7%
Renal Failure 5.7%
Vomiting 5.0%
Weight Increased 5.0%
Infection 3.8%
White Blood Cell Count Increased 3.8%
Drug Eruption 3.1%
Interstitial Lung Disease 3.1%
Rash 3.1%
Renal Disorder 3.1%
Shock 3.1%
Upper Gastrointestinal Haemorrhage 3.1%
Visual Impairment 3.1%
Death 2.5%
Depressed Level Of Consciousness 2.5%

Drug Data